
Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany
Previous positions:
Director Digital Chemistry at NUVISAN Berlin
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
Journal of Chemical Information and Modeling
(2016)
56
1622
(doi: 10.1021/acs.jcim.6b00244)
Understanding Cytotoxicity and Cytostaticity in a High-Throughput Screening Collection
ACS chemical biology
(2016)
11
3007
(doi: 10.1021/acschembio.6b00538)
Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes
J Ethnopharmacol
(2016)
197
61
(doi: 10.1016/j.jep.2016.07.058)
Synthesis and in vitro evaluation of hydrazinyl phthalazines against malaria parasite, Plasmodium falciparum
Bioorganic & Medicinal Chemistry Letters
(2016)
26
3300
(doi: 10.1016/j.bmcl.2016.05.049)
11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.
Journal of cheminformatics
(2016)
8
18
(doi: 10.1186/s13321-016-0119-5)
11th German Conference on Chemoinformatics (GCC 2015)
Journal of Cheminformatics
(2016)
8
18
(doi: 10.1186/s13321-016-0119-5)
Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway.
PloS one
(2016)
11
e0153155
(doi: 10.1371/journal.pone.0153155)
Improving the prediction of organism-level toxicity through integration of chemical, protein target and cytotoxicity qHTS data
Toxicology Research
(2016)
5
883
(doi: 10.1039/c5tx00406c)
Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data
ACS Chem Biol
(2016)
11
1255
(doi: 10.1021/acschembio.6b00029)
Global Mapping of Traditional Chinese Medicine into Bioactivity Space and Pathways Annotation Improves Mechanistic Understanding and Discovers Relationships between Therapeutic Action (Sub)classes.
Evid Based Complement Alternat Med
(2016)
2016
2106465
(doi: 10.1155/2016/2106465)
- ‹ previous
- Page 20